← Back to Search

Behavioural Intervention

Cardiac Surgery Patients for Surgery

Phase 2
Waitlist Available
Research Sponsored by Neuralert Technologies LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 days post patient surgery
Awards & highlights

Study Summary

This trial will test a new monitoring system called Neuralert to see if it can detect strokes earlier than current methods. Patients will wear the device on both arms for up to five days. The trial will

Who is the study for?
This trial is for individuals who are undergoing surgery and are at risk of stroke. Participants will be monitored using the Neuralert system to detect potential strokes early. The device will be worn on each arm for up to five days, or until battery life ends.Check my eligibility
What is being tested?
The trial is testing the Neuralert Monitoring System's ability to detect strokes more quickly than current methods. Patients wear a device on each arm that monitors them continuously, with a focus on Wi-Fi connectivity, data transmission, clinical usability, and comfort.See study design
What are the potential side effects?
Since this trial involves monitoring with a wearable device rather than medication or invasive procedures, side effects may include discomfort from wearing the devices or skin irritation where they're attached.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 days post patient surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 days post patient surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Data Aggregation
Secondary outcome measures
Stroke detection
Time to alarm reception
Time to alarm reponse

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cardiac Surgery PatientsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Neuralert Technologies LLCLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What level of risk does cardiac surgery pose for individuals?

"Based on our assessment, the safety rating for Cardiac Surgery Patients within this Phase 2 trial is deemed a 2. This implies that while there exists some safety data, no evidence supporting efficacy has been documented yet."

Answered by AI

Are individuals currently able to apply and participate in this ongoing research study?

"As per clinicaltrials.gov, recruitment for this trial is presently inactive. Originally shared on the 1st of May, 2024 and last revised on the 10th of April, 2024. Despite its current inactivity, there are currently 1417 other studies actively seeking patient enrollment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Neuralert Stroke Monitor Pilot Trial
2024. "The Neuralert Stroke Monitor Pilot Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06368193.
~13 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top